Reductive modification of genetically encoded 3-nitrotyrosine sites in alpha synuclein expressed in E.coli.


Journal

Redox biology
ISSN: 2213-2317
Titre abrégé: Redox Biol
Pays: Netherlands
ID NLM: 101605639

Informations de publication

Date de publication:
09 2019
Historique:
received: 17 05 2019
revised: 03 06 2019
accepted: 08 06 2019
pubmed: 22 6 2019
medline: 29 2 2020
entrez: 22 6 2019
Statut: ppublish

Résumé

Tyrosine nitration is a post-translational protein modification relevant to various pathophysiological processes. Chemical nitration procedures have been used to generate and study nitrated proteins, but these methods regularly lead to modifications at other amino acid residues. A novel strategy employs a genetic code modification that allows incorporation of 3-nitrotyrosine (3-NT) during ribosomal protein synthesis to generate a recombinant protein with defined 3-NT-sites, in the absence of other post-translational modifications. This approach was applied to study the generation and stability of the 3-NT moiety in recombinant proteins produced in E.coli. Nitrated alpha-synuclein (ASYN) was selected as exemplary protein, relevant in Parkinson's disease (PD). A procedure was established to obtain pure tyrosine-modified ASYN in mg amounts. However, a rapid (t

Identifiants

pubmed: 31226647
pii: S2213-2317(19)30558-0
doi: 10.1016/j.redox.2019.101251
pmc: PMC6586993
pii:
doi:

Substances chimiques

Escherichia coli Proteins 0
Recombinant Proteins 0
alpha-Synuclein 0
Green Fluorescent Proteins 147336-22-9
3-aminotyrosine 300-34-5
3-nitrotyrosine 3604-79-3
Tyrosine 42HK56048U

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

101251

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Références

J Biol Chem. 1998 Jun 5;273(23):14085-9
pubmed: 9603906
Methods. 2005 Jul;36(3):227-38
pubmed: 16076448
J Neuropathol Exp Neurol. 1998 Apr;57(4):338-42
pubmed: 9600227
Science. 2000 Nov 3;290(5493):985-9
pubmed: 11062131
Science. 2001 Apr 20;292(5516):498-500
pubmed: 11313494
Antioxid Redox Signal. 2012 Nov 15;17(10):1393-406
pubmed: 22578329
Angew Chem Int Ed Engl. 2010 Sep 17;49(39):7049-53
pubmed: 20715234
Biochem Pharmacol. 2005 Sep 15;70(6):811-23
pubmed: 15899473
Chembiochem. 2017 Dec 5;18(23):2312-2316
pubmed: 28980756
J Am Chem Soc. 2015 Apr 22;137(15):5041-52
pubmed: 25768729
Chem Res Toxicol. 1992 Nov-Dec;5(6):834-42
pubmed: 1336991
Redox Biol. 2018 Apr;14:618-625
pubmed: 29154193
Tanaffos. 2012;11(4):23-9
pubmed: 25191434
J Mol Biol. 1990 Jun 20;213(4):719-26
pubmed: 2141650
Chem Commun (Camb). 2013 Oct 18;49(81):9254-6
pubmed: 23995579
Biochemistry. 2007 Jun 26;46(25):7325-36
pubmed: 17542619
IUBMB Life. 2008 Jan;60(1):73-8
pubmed: 18379995
J Neurosci. 1997 Apr 15;17(8):2653-7
pubmed: 9092586
J Mol Biol. 2010 Jan 15;395(2):361-74
pubmed: 19852970
J Neurochem. 2013 May;125(4):491-511
pubmed: 23452040
Arch Biochem Biophys. 1992 Nov 1;298(2):431-7
pubmed: 1416974
J Biol Chem. 2000 Jun 16;275(24):18344-9
pubmed: 10747881
Chem Biol. 2001 Sep;8(9):883-90
pubmed: 11564556
Brain Res Mol Brain Res. 2005 Mar 24;134(1):84-102
pubmed: 15790533
Microb Cell Fact. 2012 May 08;11:56
pubmed: 22569138
Am J Physiol. 1996 Nov;271(5 Pt 1):C1424-37
pubmed: 8944624
J Am Chem Soc. 2008 Mar 26;130(12):4028-33
pubmed: 18321101
Biochemistry. 2014 Apr 1;53(12):1916-24
pubmed: 24611875
Proc Natl Acad Sci U S A. 2018 Jun 5;115(23):5839-5848
pubmed: 29802228
Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):6705-10
pubmed: 9618476
Biol Chem. 1997 Jul;378(7):707-13
pubmed: 9278151
Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13136-41
pubmed: 10557286
FASEB J. 2005 Jul;19(9):1169-71
pubmed: 15878931
J Am Chem Soc. 2012 Mar 21;134(11):5196-210
pubmed: 22339654
Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6640-5
pubmed: 10829079
Mol Cell Biochem. 1999 Nov;201(1-2):11-6
pubmed: 10630617
J Am Chem Soc. 2010 Jun 23;132(24):8385-97
pubmed: 20518462
Chem Rev. 2018 Feb 14;118(3):1338-1408
pubmed: 29400454
Am J Physiol Heart Circ Physiol. 2013 Sep 1;305(5):H687-98
pubmed: 23792683
Bioinformatics. 2002 Jun;18(6):884-5
pubmed: 12075025
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3481-6
pubmed: 11904413
Proc Natl Acad Sci U S A. 2005 Feb 1;102(5):1430-5
pubmed: 15671169
Biochem Biophys Res Commun. 1967 Apr 7;27(1):20-5
pubmed: 6048236
Arch Microbiol. 2002 Sep;178(3):193-201
pubmed: 12189420
Chembiochem. 2011 Sep 5;12(13):2016-20
pubmed: 21748837
Anal Chem. 2006 Apr 1;78(7):2422-31
pubmed: 16579629
J Biol Chem. 2011 Feb 18;286(7):4991-5002
pubmed: 21081502

Auteurs

Hanne R Gerding (HR)

In Vitro Toxicology and Biomedicine, Department of Biology, University of Konstanz, 78457, Konstanz, Germany.

Christiaan Karreman (C)

In Vitro Toxicology and Biomedicine, Department of Biology, University of Konstanz, 78457, Konstanz, Germany.

Andreas Daiber (A)

Zentrum für Kardiologie, Johannes Gutenberg Universität Mainz, 55131, Mainz, Germany.

Johannes Delp (J)

In Vitro Toxicology and Biomedicine, Department of Biology, University of Konstanz, 78457, Konstanz, Germany.

Daniel Hammler (D)

Research School Chemical Biology, Department of Chemistry, University of Konstanz, 78457, Konstanz, Germany.

Martin Mex (M)

Research School Chemical Biology, Department of Chemistry, University of Konstanz, 78457, Konstanz, Germany.

Stefan Schildknecht (S)

In Vitro Toxicology and Biomedicine, Department of Biology, University of Konstanz, 78457, Konstanz, Germany. Electronic address: Stefan.Schildknecht@uni-konstanz.de.

Marcel Leist (M)

In Vitro Toxicology and Biomedicine, Department of Biology, University of Konstanz, 78457, Konstanz, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH